ArticleClinical parkinsonism & related disorders2025
Patterns and causes of supranuclear vertical gaze palsy: A retrospective, single-institutional study in 113 patients.
Article in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Supranuclear vertical gaze palsy (SVGP) is a hallmark feature of progressive supranuclear gaze palsy (PSP). However, it can also occur in a variety of other disorders affecting the upper brainstem. The aim of this study was to provide an overview of potential etiologies of SVGP, and to characterize the associated clinical features. Methods: We retrospectively analyzed data of all patients presenting with SVGP in inpatient and outpatient care in the University Hospital for Neurology Graz between January 2012 and June 2022. SVGP was diagnosed clinically by neurologists and all diagnoses were established based on clinical evaluation. Results: Of the included 113 patients (66 males, 47 females; mean age: 67.5 years) the most common etiologies were Parkinsonian (n = 50) and vascular disorders (n = 43). Other underlying diagnoses were ataxia syndromes (n = 2), other neurodegenerative disorders (n = 8), autoimmune and inflammatory disorders (n = 3), lysosomal storage diseases (n = 2), neoplastic lesions (n = 2), and others (n = 2). Among Parkinsonian disorders, PSP represented the most frequent diagnosis (n = 37). All patients with downward SVGP were diagnosed with PSP and frequently exhibited additional oculomotor symptoms. In contrast, upward SVGP was more common in Parkinson's disease (PD) (p = 0.004). Vascular lesions were located in the mesencephalon (n = 20), thalamus (n = 10), cerebellum (n = 3), and pons (n = 2) and were more commonly associated with upward SVGP (n = 35) than downward SVGP (n = 3). Similarly, other etiologies were more often linked to upward SVGP (n = 14) than downward SVGP (N = 5). Conclusion: Parkinsonian and vascular disorders are the most common etiologies of SVGP, but a wide range of disorders must be considered. While upward SVGP has a broad differential diagnosis, downward SVGP is predominantly seen in patients with PSP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.